The Correlation Between Aldosterone and Leukocyte-Related Inflammation: A Comparison Between Patients with Primary Aldosteronism and Essential Hypertension

The Correlation Between Aldosterone and Leukocyte-Related Inflammation: A Comparison Between Patients with Primary Aldosteronism and Essential Hypertension

Kun-Rui Rao,1,&ast; Ru-Yi Bao,1,&ast; Hu Ming,1 Jian-Wei Liu,1 Yi-Fei Dong1,2 1Department of Cardiovascular Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, People’s Republic of China; 2Key Laboratory of Molecular Biology in Jiangxi Province, Nanchang, People’s Repu...

Full description

Bibliographic Details
Main Authors:	Rao KR, Bao RY, Ming H, Liu JW, Dong YF
Format:	Article
Language:	English
Published:	Dove Medical Press 2023-06-01
Series:	Journal of Inflammation Research
Subjects:	aldosterone inflammation leukocytes primary aldosteronism essential hypertension
Online Access:	https://www.dovepress.com/the-correlation-between-aldosterone-and-leukocyte-related-inflammation-peer-reviewed-fulltext-article-JIR

Similar Items

Predictive performance of aldosterone-to-renin ratio in the diagnosis of primary aldosteronism in patients with resistant hypertension
by: Fabio Bioletto, et al.
Published: (2023-05-01)

Functional Characteristic and Significance of Aldosterone-Producing Cell Clusters in Primary Aldosteronism and Age-Related Hypertension
by: Fatin Athirah Pauzi, et al.
Published: (2021-03-01)

Primary Aldosteronism and Pregnancy
by: Tomáš Zelinka, et al.
Published: (2020-02-01)

Cutoff Values of Aldosterone and the Aldosterone–Renin Ratio for Predicting Primary Aldosteronism in Patients with Resistant Hypertension: A Real-Life Study
by: João Vicente da Silveira, et al.
Published: (2024-09-01)

Elderly men are underscreened for primary aldosteronism even in Hypertension Excellence Centre
by: Avital Angel Korman, et al.
Published: (2024-12-01)

The prevalence of metabolic syndrome in primary aldosteronism and essential hypertension: A systematic review and meta‐analysis
by: Kaiwen Sun, et al.
Published: (2024-08-01)

Who needs to be screened for primary aldosteronism?
by: Wei-Chieh Huang, et al.
Published: (2024-03-01)

Aldosterone-to-renin ratio (ARR) as a screening tool for primary aldosteronism (PA)
by: Chia-Hung Lin, et al.
Published: (2024-03-01)

Update on Genetics of Primary Aldosteronism
by: Kiyotaka Itcho, et al.
Published: (2021-04-01)

Clinical characteristics of primary aldosteronism screened from Chinese patients with hypertension: The China primary aldosteronism prospective study
by: Zhe Hu, et al.
Published: (2024-09-01)

The differences of serum lipid profiles between primary aldosteronism and essential hypertension: a meta-analysis and systematic review
by: Worapaka Manosroi, et al.
Published: (2022-08-01)

Pathogenesis of Primary Aldosteronism: Impact on Clinical Outcome
by: Lucas S. Santana, et al.
Published: (2022-06-01)

Treatment of primary aldosteronism: Clinical practice guidelines of the Taiwan Society of Aldosteronism
by: Chi-Shin Tseng, et al.
Published: (2024-03-01)

Aldosterone-producing adenoma is associated with urolithiasis in primary aldosteronism
by: Victor Jing-Wei Kang, et al.
Published: (2023-08-01)

Who should be screened for primary aldosteronism? A comprehensive review of current evidence
by: Wei‐Chieh Huang, et al.
Published: (2022-09-01)

Primary Aldosteronism Screening Rates Differ with Sex, Race, and Comorbidities
by: Adina F. Turcu, et al.
Published: (2022-07-01)

The Relationship Between Renal Stones and Primary Aldosteronism
by: Chun-Kai Chang, et al.
Published: (2022-02-01)

The Interplay Between the Renin-Angiotensin-Aldosterone System and Parathyroid Hormone
by: Ming-Hui Zheng, et al.
Published: (2020-08-01)

Safety and efficacy of once-daily dexfadrostat phosphate in patients with primary aldosteronism: a randomised, parallel group, multicentre, phase 2 trialResearch in context
by: Paolo Mulatero, et al.
Published: (2024-05-01)

Comparison between screening for primary aldosteronism with and without drug adjustment
by: Yanlong Hua, et al.
Published: (2024-12-01)

Primary aldosteronism and pregnancy
by: V.I. Medved, et al.
Published: (2022-05-01)

Mutation in Aldosterone Producing Adenoma
by: Jian-Jhong Wang, et al.
Published: (2017-09-01)

Incidental Congestive Heart Failure in Patients With Aldosterone‐Producing Adenomas
by: Wei‐Chieh Huang, et al.
Published: (2019-12-01)

Mineralocorticoid Receptor-Dependent Impairment of Baroreflex Contributes to Hypertension in a Mouse Model of Primary Aldosteronism
by: Luo Shi, et al.
Published: (2019-11-01)

THE CORRELATION BETWEEN THE RENIN AT ALDOSTERONE SYSTEM – ARTERIAL HYPERTENSION AND HORMONAL MECHANISMS
by: Liviu Stafie, et al.
Published: (2024-09-01)

Captopril challenge test in the diagnosis of primary aldosteronism: consistency between 1- and 2- h sampling
by: Xinyu Liu, et al.
Published: (2023-06-01)

Primary aldosteronism: current diagnostic approach
by: Elena S. Eniseeva
Published: (2022-12-01)

Effects of chronically high levels of aldosterone on different cognitive dimensions: an investigation in patients with primary aldosteronism
by: Lukas Engler, et al.
Published: (2019-04-01)

Primary aldosteronism caused by a pI157S somatic KCNJ5 mutation in a black adolescent female with aldosterone-producing adenoma
by: Celso E. Gomez-Sanchez, et al.
Published: (2022-08-01)

Screening parameters for diagnosing primary aldosteronism in patients with moderate to severe obstructive sleep apnea hypopnea syndrome and resistant hypertension
by: Dien Yan, et al.
Published: (2024-04-01)

Survey of renin and aldosterone testing practices by Ontario laboratories – Providing insight into best practices
by: Angela C. Rutledge, et al.
Published: (2021-05-01)

Pitfalls in the diagnosis and treatment of a hypertensive patient with unilateral primary aldosteronism and contralateral pheochromocytoma: a case report
by: Shotaro Miyamoto, et al.
Published: (2023-02-01)

Fifty years of subclinical primary aldosteronism: Importance of early diagnosis
by: Ćirić Jasmina, et al.
Published: (2012-01-01)

Diagnostic uncertainty in primary aldosteronism
by: Marković Bojan, et al.
Published: (2024-01-01)

Divergent Characteristics of T-Cell Receptor Repertoire Between Essential Hypertension and Aldosterone-Producing Adenoma
by: Che-Mai Chang, et al.
Published: (2022-05-01)

Target organ damage in untreated hypertensive patients with primary aldosteronism
by: Shi‐Min Li, et al.
Published: (2024-07-01)

Primary aldosteronism with postoperative elevation of aldosterone treated effectively by finerenone: A case report
by: Cai‐Guo Yu, et al.
Published: (2024-09-01)

Impact of the transition from radioimmunoassay (RIA) to chemiluminescent enzyme immunoassay (CLEIA) for the measurement of plasma aldosterone concentration (PAC) on the diagnosis of primary aldosteronism (PA) via retrospective analyses in Okinawa, Japan
by: Ken-ichiro Honma, et al.
Published: (2024-09-01)

Plasma aldosterone response to ACTH stimulation test for diagnosis of primary aldosteronism: a cross-sectional study
by: Worapaka Manosroi, et al.
Published: (2024-03-01)

Associations Between Metabolic Profiles and Target-Organ Damage in Chinese Individuals With Primary Aldosteronism
by: Shao-Ling Zhang, et al.
Published: (2020-09-01)